{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:55:46Z","timestamp":1780541746184,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,13]]},"DOI":"10.7759\/cureus.82167","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T11:46:13Z","timestamp":1744544773000},"source":"Crossref","is-referenced-by-count":1,"title":["Immune Thrombocytopenia Induced by Helicobacter pylori Infection: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Almaali","family":"Alrakha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"ElGohary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23262","article-title":"Prevalence of primary immune thrombocytopenia in Oklahoma","volume":"87","author":"Terrell DR","year":"2012","unstructured":"Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012, 87:848-52. 10.1002\/ajh.23262","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2007.06.007","article-title":"Immune thrombocytopenic purpura","volume":"21","author":"Psaila B","year":"2007","unstructured":"Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin North Am. 2007, 21:743-59, vii. 10.1016\/j.hoc.2007.06.007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5045\/br.2017.52.4.254","article-title":"Management of immune thrombocytopenia: Korean experts recommendation in 2017","volume":"52","author":"Jang JH","year":"2017","unstructured":"Jang JH, Kim JY, Mun YC, et al.. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Blood Res. 2017, 52:254-63. 10.5045\/br.2017.52.4.254","journal-title":"Blood Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini A","year":"1998","unstructured":"Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998, 352:878. 10.1016\/S0140-6736(05)60004-9","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1683974","article-title":"Management of Helicobacter pylori in patients with immune thrombocytopenia","volume":"39","author":"Vanegas YA","year":"2019","unstructured":"Vanegas YA, Vishnu P. Management of Helicobacter pylori in patients with immune thrombocytopenia. Hamostaseologie. 2019, 39:279-83. 10.1055\/s-0039-1683974","journal-title":"Hamostaseologie"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5551","article-title":"Helicobacter pylori: an underrated cause of immune thrombocytopenic purpura. A comprehensive review","volume":"11","author":"Zain MA","year":"2019","unstructured":"Zain MA, Zafar F, Ashfaq A, Jamil AR, Ahmad A. Helicobacter pylori: an underrated cause of immune thrombocytopenic purpura. A comprehensive review. Cureus. 2019, 11:e5551. 10.7759\/cureus.5551","journal-title":"Cureus"},{"key":"ref7","article-title":"[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]","volume":"42","author":"Goto H","year":"2001","unstructured":"Goto H, Kikuta T, Ota A, Tsuji H, Hino R. [Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. Rinsho Ketsueki. 2001, 42:1192-4.","journal-title":"Rinsho Ketsueki"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4021\/gr2009.02.1271","article-title":"Chronic idiopathic thrombocytopenia purpura and Helicobacter pylori eradication: a case study","volume":"2","author":"Tiwari SK","year":"2009","unstructured":"Tiwari SK, G M, Khan AA, Habeeb A, Habibullah CM. Chronic idiopathic thrombocytopenia purpura and Helicobacter pylori eradication: a case study. Gastroenterology Res. 2009, 2:57-9. 10.4021\/gr2009.02.1271","journal-title":"Gastroenterology Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.8856","article-title":"Ulcerative colitis accompanied by idiopathic thrombocytopenic purpura and Helicobacter pylori infection","volume":"52","author":"Etou T","year":"2013","unstructured":"Etou T, Iizuka M, Ohshima A, Yagisawa H, Yamano HO, Ishii T, Sagara S. Ulcerative colitis accompanied by idiopathic thrombocytopenic purpura and Helicobacter pylori infection. Intern Med. 2013, 52:547-9. 10.2169\/internalmedicine.52.8856","journal-title":"Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-205786","article-title":"From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia","volume":"2014","author":"Hill LJ","year":"2014","unstructured":"Hill LJ, Tung EE. From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia. BMJ Case Rep. 2014, 2014:bcr201420578. 10.1136\/bcr-2014-205786","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2018.12.002","article-title":"Immune thrombocytopenia associated with Helicobacter pylori - unclear associative mechanisms","volume":"41","author":"Marques AR","year":"2019","unstructured":"Marques AR, Sousa L, Mendes M, Apolin\u00e1rio I. Immune thrombocytopenia associated with Helicobacter pylori - unclear associative mechanisms. Hematol Transfus Cell Ther. 2019, 41:272-4. 10.1016\/j.htct.2018.12.002","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2021.1973293","article-title":"Immune thrombocytopenic purpura secondary to Helicobacter pylori","volume":"35","author":"Ramachandran L","year":"2022","unstructured":"Ramachandran L, Baloch L, Djirdeh TM, Sidhu Y, Gentile N, Affinati M. Immune thrombocytopenic purpura secondary to Helicobacter pylori. Proc (Bayl Univ Med Cent). 2022, 35:60-1. 10.1080\/08998280.2021.1973293","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27809","article-title":"Immune thrombocytopenia induced by Helicobacter pylori infection: a case report and literature review","volume":"14","author":"Sadia H","year":"2022","unstructured":"Sadia H, Abro S, Ali M, et al.. Immune thrombocytopenia induced by Helicobacter pylori infection: a case report and literature review. Cureus. 2022, 14:e27809. 10.7759\/cureus.27809","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/children9091352","article-title":"Helicobacter pylori-related extraintestinal manifestations-myth or reality","volume":"9","author":"M\u0103rginean CD","year":"2022","unstructured":"M\u0103rginean CD, M\u0103rginean CO, Meli\u021b LE. Helicobacter pylori-related extraintestinal manifestations-myth or reality. Children (Basel). 2022, 9:1352. 10.3390\/children9091352","journal-title":"Children (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04735.x","article-title":"Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura","volume":"124","author":"Takahashi T","year":"2004","unstructured":"Takahashi T, Yujiri T, Shinohara K, et al.. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004, 124:91-6. 10.1046\/j.1365-2141.2003.04735.x","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.9.1033","article-title":"Autoimmune thrombocytopenic purpura and Helicobacter pylori infection","volume":"162","author":"Michel M","year":"2002","unstructured":"Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B, Bierling P. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med. 2002, 162:1033-6. 10.1001\/archinte.162.9.1033","journal-title":"Arch Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34496","article-title":"Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients","volume":"118","author":"Asahi A","year":"2008","unstructured":"Asahi A, Nishimoto T, Okazaki Y, et al.. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest. 2008, 118:2939-49. 10.1172\/JCI34496","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20250","article-title":"Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature","volume":"78","author":"Jackson S","year":"2005","unstructured":"Jackson S, Beck PL, Pineo GF, Poon MC. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am J Hematol. 2005, 78:142-50. 10.1002\/ajh.20250","journal-title":"Am J Hematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3934\/microbiol.2021018","article-title":"Helicobacter pylori induced immune thrombocytopenic purpura and perspective role of Helicobacter pylori eradication therapy for treating immune thrombocytopenic purpura","volume":"7","author":"Ihtesham A","year":"2021","unstructured":"Ihtesham A, Maqbool S, Nadeem M, et al.. Helicobacter pylori induced immune thrombocytopenic purpura and perspective role of Helicobacter pylori eradication therapy for treating immune thrombocytopenic purpura. AIMS Microbiol. 2021, 7:284-303. 10.3934\/microbiol.2021018","journal-title":"AIMS Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines DB","year":"2009","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009, 113:6511-21. 10.1182\/blood-2009-01-129155","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert C","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011, 117:4190-207. 10.1182\/blood-2010-08-302984","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i18.5461","article-title":"Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development","volume":"20","author":"Watari J","year":"2014","unstructured":"Watari J, Chen N, Amenta PS, et al.. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014, 20:5461-73. 10.3748\/wjg.v20.i18.5461","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen YC","year":"2000","unstructured":"Cohen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 2000, 160:1630-8. 10.1001\/archinte.160.11.1630","journal-title":"Arch Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225565","article-title":"International consensus report on the investigation and management of primary immune thrombocytopenia","volume":"115","author":"Provan D","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, et al.. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010, 115:168-86. 10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2018.1.568","article-title":"Evidence-based management of immune thrombocytopenia: ASH guideline update","volume":"2018","author":"Neunert CE","year":"2018","unstructured":"Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology Am Soc Hematol Educ Program. 2018, 2018:568-75. 10.1182\/asheducation-2018.1.568","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12200","article-title":"Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography","volume":"20","author":"Frydman GH","year":"2015","unstructured":"Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: a review and the role of biogeography. Helicobacter. 2015, 20:239-51. 10.1111\/hel.12200","journal-title":"Helicobacter"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343957-immune-thrombocytopenia-induced-by-helicobacter-pylori-infection-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T11:46:13Z","timestamp":1744544773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343957-immune-thrombocytopenia-induced-by-helicobacter-pylori-infection-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,13]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.82167","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,13]]}}}